BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Radware
RDWR
$1.25B
| $40.3M | ﹤0.01% |
1,193,709
+87,285
| +8% | +$2.89M |
|
2802
PAVmed
PAVM
$33.9M
| $40.2M | ﹤0.01% |
10,452
+128
| +1% | +$404K |
|
2803
ING
ING
$102B
| $40M | ﹤0.01% |
2,759,763
-1,868
| -0.1% | -$25K |
|
|
VBIV
2804
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $39.8M | ﹤0.01% |
426,881
-2,542
| -0.6% | -$242K |
|
2805
Procore
PCOR
$9.45B
| $39.8M | ﹤0.01% |
445,422
+124,400
| +39% | +$11.7M |
|
2806
Lennar Class B
LEN.B
$20.7B
| $39.8M | ﹤0.01% |
539,425
+13,290
| +3% | +$1.06M |
|
2807
Ducommun
DCO
$3.01B
| $39.8M | ﹤0.01% |
789,691
-29,426
| -4% | -$1.54M |
|
2808
Cytek Biosciences
CTKB
$636M
| $39.7M | ﹤0.01% |
+1,854,743
| New | +$43.6M |
|
2809
iShares US Small Cap Equity Factor ETF
SMLF
$4.32B
| $39.7M | ﹤0.01% |
738,388
+77,258
| +12% | +$4.22M |
|
2810
Praxis Precision Medicines
PRAX
$10.3B
| $39.7M | ﹤0.01% |
142,978
+42,046
| +42% | +$11.4M |
|
2811
Napco Security Technologies
NSSC
$1.37B
| $39.6M | ﹤0.01% |
1,838,360
+766
| +0% | +$14.3K |
|
|
OHPAU
2812
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $39.6M | ﹤0.01% |
4,000,000
| – | – |
|
|
PAE
2813
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $39.5M | ﹤0.01% |
6,612,152
+35,478
| +0.5% | +$271K |
|
2814
Sabesp
SBS
$16.5B
| $39.4M | ﹤0.01% |
28,684,508
+762,397
| +3% | +$1.01M |
|
2815
Hyster-Yale Materials Handling
HY
$617M
| $39.3M | ﹤0.01% |
781,579
-6,223
| -0.8% | -$383K |
|
2816
Mission Produce
AVO
$1.15B
| $39.3M | ﹤0.01% |
2,136,346
+75,406
| +4% | +$1.48M |
|
2817
Bank of Montreal
BMO
$129B
| $39.2M | ﹤0.01% |
393,368
-42
| -0% | -$4.23K |
|
|
ALX
2818
Alexander's
ALX
$1.4B
| $39.2M | ﹤0.01% |
150,233
-54,890
| -27% | -$14.7M |
|
2819
Stoneridge
SRI
$201M
| $39.1M | ﹤0.01% |
1,920,008
-48,906
| -2% | -$1.21M |
|
|
VIEW
2820
DELISTED
View, Inc. Class A Common Stock
VIEW
| $39.1M | ﹤0.01% |
120,367
+10,733
| +10% | +$3.77M |
|
|
VRS
2821
DELISTED
Verso Corporation
VRS
| $39.1M | ﹤0.01% |
1,882,179
-218,302
| -10% | -$4.21M |
|
|
AERI
2822
DELISTED
Aerie Pharmaceuticals
AERI
| $39M | ﹤0.01% |
3,423,667
+91,258
| +3% | +$1.33M |
|
|
CATC
2823
DELISTED
CAMBRIDGE BANCORP
CATC
| $39M | ﹤0.01% |
443,320
+969
| +0.2% | +$81.6K |
|
2824
Blend Labs
BLND
$367M
| $39M | ﹤0.01% |
+2,890,629
| New | +$49.1M |
|
|
DFTX
2825
Definium Therapeutics
DFTX
$5.9B
| $38.9M | ﹤0.01% |
1,112,133
+66,499
| +6% | +$2.87M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.